Adverum Biotechnologies, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABSI
Absci Corporation |
$3.37 | $495.31 M | -3.78 | 155 | $5.72 M |
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.79 | $223.86 M | -2.51 | 58 | $0 |
ADAG
Adagene Inc. |
$1.98 | $131.46 M | -6.77 | 174 | $18.11 M |
AFMD
Affimed N.V. |
$1.36 | $93.50 M | -0.8 | 76 | $8.28 M |
ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GLMD
Galmed Pharmaceuticals Ltd. |
$3.02 | $2.04 M | -0.21 | 3 | $0 |
KOD
Kodiak Sciences Inc. |
$9.32 | $151.83 M | -0.65 | 108 | $0 |
KZR
Kezar Life Sciences, Inc. |
$6.65 | $49.85 M | -0.49 | 58 | $7.00 M |
MGTX
MeiraGTx Holdings plc |
$6.34 | $306.74 M | -4.01 | 389 | $14.02 M |
MREO
Mereo BioPharma Group plc |
$3.76 | $479.72 M | -22.8 | 33 | $10.00 M |
ONCT
Oncternal Therapeutics, Inc. |
$0.53 | $24.27 M | -0.67 | 27 | $785,000 |
PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
QURE
uniQure N.V. |
$18.08 | $258.77 M | -0.86 | 209 | $27.12 M |
RCKT
Rocket Pharmaceuticals, Inc. |
$12.35 | $2.06 B | -7.96 | 299 | $0 |
RYTM
Rhythm Pharmaceuticals, Inc. |
$58.97 | $2.44 B | -8.63 | 283 | $130.13 M |
RZLT
Rezolute, Inc. |
$5.21 | $229.57 M | -5.02 | 64 | $0 |
SLDB
Solid Biosciences Inc. |
$4.10 | $309.34 M | -2.05 | 100 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
